Dupilumab-Associated Mycosis Fungoides with a CD8+ Immunophenotype

• Κύριοι συγγραφείς: Ariel Park (Συγγραφέας), Lulu Wong (Συγγραφέας), Annalise Lang (Συγγραφέας), Christina Kraus (Συγγραφέας), Nancy Anderson (Συγγραφέας), Ashley Elsensohn (Συγγραφέας)
• Μορφή: Βιβλίο
• Έκδοση: MDPI AG, 2022-11-01T00:00:00Z.
• Θέματα: article
• Διαθέσιμο Online: Connect to this object online.

Dupilumab is a humanized IgG4 monoclonal-antibody that is approved by the United States Food and Drug Administration (FDA) for the treatment of moderate-to-severe atopic dermatitis (AD) in patients aged 12 years and older. In recent years, several case studies have associated the unmasking or progre...